The stroke care revolution.
D003226:Congresses as Topic; D003362:Cost-Benefit Analysis; D057510:Endovascular Procedures / Q000191:economics; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000191:economics / Q000601:surgery*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed / Q000379:methods; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator